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The restriction factor BST-2/tetherin contains two
membrane anchors employed to retain some envel-
oped viruses, including HIV-1 tethered to the plasma
membrane in the absence of virus-encoded antago-
nists. The 2.77 A˚ crystal structure of the BST-2/
tetherin extracellular core presented here reveals a
parallel 90 A˚ long disulfide-linked coiled-coil domain,
while the complete extracellular domain forms an
extended 170 A˚ long rod-like structure based on
small-angle X-ray scattering data. Mutagenesis
analyses indicate that both the coiled coil and the
N-terminal region are required for retention of HIV-1,
suggesting that the elongated structure can function
as a molecular ruler to bridge long distances. The
structure reveals substantial irregularities and insta-
bilities throughout the coiled coil, which contribute
to its low stability in the absence of disulfide bonds.
We propose that the irregular coiled coil provides
conformational flexibility, ensuring that BST-2/teth-
erin anchoring both in the plasma membrane and
in the newly formed virus membrane is maintained
during virus budding.
INTRODUCTION
Enveloped viruses rely on host cell factors to complete their life
cycle. These factors act as positive or negative regulators, such
as restriction factors, that often limit replication to a narrow range
of hosts and cell types (Malim and Emerman, 2008). While
restriction factors are inducible by IFN and thus constitute a first
line of innate immune defense, viral proteins that render cells
permissive for infection can counteract this mechanism. Certain
cell types, such as HeLa cells, require the expression of the
HIV-1 cofactor Vpu for particle release (Go¨ttlinger et al., 1993;
Klimkait et al., 1990; Strebel et al., 1989; Terwilliger et al.,
1989), although replication occurs independently of Vpu in other
cells (Gramberg et al., 2009; Strebel et al., 2009). This restriction314 Cell Host & Microbe 7, 314–323, April 22, 2010 ª2010 Elsevier Inwas attributed to the presence or absence of BST-2, also known
as tetherin (or CD317 and HM1.24) (Neil et al., 2008; Van Damme
et al., 2008). BST-2/tetherin was originally linked to B cell devel-
opment and shown to be a marker of multiple myeloma cells
(Goto et al., 1994; Masuyama et al., 2009; Ohtomo et al.,
1999). Its expression is induced by IFN-a (Kawai et al., 2008),
and IFN-a activation leads to HIV-1 retention at the plasma
membrane in the absence of Vpu (Neil et al., 2007).
BST-2/tetherin is a type II transmembrane protein composed
of a small cytosolic domain, an N-terminal transmembrane
region (TMR), and an extracellular domain modified by a second
membrane anchor, a C-terminal glycosyl-phosphatidylinositol
(GPI) (Kupzig et al., 2003). BST-2/tetherin resides in lipid rafts
at the cell surface and membranes of the trans Golgi network
(TGN) (Kupzig et al., 2003). In HIV-1-infected cells, tetherin is
retained in the TGN by Vpu (Neil et al., 2008; Van Damme et al.,
2008) and targeted for endocytosis and degradation (Douglas
et al., 2009; Goffinet et al., 2009; Harila et al., 2007; Mangeat
et al., 2009; Mitchell et al., 2009), although it should be noted
that enhancement of virus release by Vpu does not depend on
downregulation or degradation of tetherin in some specific cell
lines (Miyagi et al., 2009).
Inhibition of tetherin by Vpu is species specific and suggests
that Vpu’s activity evolved to specifically counteract human teth-
erin (Goffinet et al., 2009; Gupta et al., 2009; Jia et al., 2009;
Sauter et al., 2009). Vpu-mediated tetherin retention requires
the TMR of tetherin (McNatt et al., 2009; Rong et al., 2009) or
all structural domains (Goffinet et al., 2009) and the TMR and
cytosolic domain of Vpu (Van Damme et al., 2008).
The antiviral function of tetherin is not limited to HIV-1 or
other retroviruses (Jouvenet et al., 2009; Zhang et al., 2009)
as it also restricts release of filoviruses (Jouvenet et al., 2009;
Kaletsky et al., 2009), arena viruses (Sakuma et al., 2009a),
and KSHV (Bartee et al., 2006) in the absence of their respective
antagonists.
Tetherin has been suggested to span both the cellular and viral
membranes (Neil et al., 2008) based on its double-membrane-
anchored topology (Kupzig et al., 2003), its ability to form
disulfide-linked dimers (Ohtomo et al., 1999), and the presence
of a predicted coiled-coil sequence in the extracellular domain.
Tetherin is present in the viral membrane as a homodimer,
and either TMR or the GPI anchor must be inserted into virionc.
Figure 1. Biochemical Characterization of the Extracellular Domain
of Tetherin
(A) SEC analysis of tetherin(47-159) and tetherin(80-147).
(B) SDS-PAGE of tetherin(47-159) (lanes 1 and 3) and tetherin(80-147) under
reducing (lanes 1 and 2) and nonreducing conditions (lanes 3 and 4).
(C) Reduced tetherin(47-159) and tetherin(80-147) still dimerize; tetherin
(47-159) (lanes 1, 3, 4) and tetherin(80-147) (lanes 2, 5, 6) were treated with
iodoacetamide and separated under nonreducing conditions (lanes 1 and 2),
under reducing conditions (lanes 3 and 5), and after crosslinking with 5 mM
EGS (lanes 4 and 6). Dimers are indicated by *.
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Crystal Structure of BST-2/Tetherinenvelopes for successful retention (Perez-Caballero et al., 2009).
Furthermore, disulfide crosslinking via any of the three cysteines
and the spacer function of the coiled coil are necessary for anti-
viral activity (Andrew et al., 2009; Perez-Caballero et al., 2009).
Here, we present the crystal structure of a core fragment of
human tetherin, which forms a 90 A˚ long parallel coiled coil. The
complete extracellular region adopts a 170 A˚ long bent rod-
like structure based on small-angle X-ray scattering analysis,
defining the extracellular domain as a molecular ruler that
keeps both membrane anchors at a certain distance. The coiled
coil contains a number of destabilizing residues at central
heptad positions, which are conserved among all known tetherin
sequences. Consequently, both the core of tetherin and the
complete extracellular domain show a dramatic loss in thermosta-
bility upon disulfide bond reduction in vitro. Mutagenesis analyses
reveal that the coiled coil must be intact for function and identify
an N-terminal conserved region that is required for HIV-1 restric-
tion. The structure of tetherin explains how it can bridge long
distances using a labile parallel coiled coil. Thus, tetherin has
enough flexibility to insert one membrane anchor into a budding
virion while the other anchor remains in the plasma membrane
and excluded from the site directly involved in budding.
RESULTS
Recombinant Tetherin Forms Dimers
Recombinant tetherin(47-159) elutes from a SEC column at
10.0 ml (Figure 1A); it migrates at 13 kDa under reducing
and at 26 kDa under nonreducing conditions on SDS-PAGE,
indicating disulfide-linked dimerization (Figure 1B). Since crys-
tals produced from tetherin(47-159) did not diffract beyond
10 A˚ resolution, we applied limited trypsin proteolysis to define
a smaller fragment containing residues 80–147. Tetherin(80-147)
elutes from a SEC column at 11.3 ml (Figure 1A) and reveals
disulfide-linked dimerization based on SDS-PAGE analysis
under reducing and nonreducing conditions (Figure 1B). In order
to test whether dimerization depends mainly on disulfide-medi-
ated crosslinking, both tetherin(47-159) and tetherin(80-147)
were reduced with DTT, and cysteines were subsequently
blocked with iodoacetamide; this treatment produces mostly
monomeric tetherin under nonreducing SDS-PAGE conditions
(Figure 1C, lanes 1 and 2). Chemical crosslinking reveals that
both constructs still dimerize, as indicated by the appearance
of new bands migrating at 27 kDa (tetherin[47-159]) and
between 15 and 20 kDa (tetherin[80-147]) (Figure 1C, lanes 4
and 6). Circular dichroism analyses show a high helical content
(90% helical) for both constructs (Figure 2A). Although the
helical content does not change for tetherin(47-159) in the pre-
sence of DTT, tetherin(80-147) displays a reduced helical con-
tent (70%) (Figure 2A). The effect of the reducing agent was
more dramatic when thermostability was tested. While teth-
erin(47-159) and tetherin(80-147) show melting temperatures
(Tm) of61C and57C, respectively, disulfide bond reduction
drops the Tm to 35C and 30C, respectively (Figure 2B). The
influence of disulfide bond linkage on the structure is further
corroborated by the increased sensitivity of both constructs
to complete degradation by trypsin treatment under reducing
conditions (Figure S1). These results indicate that dimer stability
greatly depends on intermolecular disulfide bonds.CellCrystal Structure of Tetherin(80-147)
The crystal structure of tetherin(80-147) was determined from
a selenomethionine-containing crystal using the single anoma-
lous dispersion (SAD) method and diffraction data to 2.77 A˚
resolution, which produced a readily interpretable electron
density map (Figure 3A). The asymmetric crystal unit contained
11 monomers that, together with crystallographic symmetry,
formed six identical dimers. The best-defined dimer contains
residues 89–147 and folds into a disulfide-linked 90 A˚ long
parallel coiled coil (Figures 3B). The N-terminal residues 80–88
are disordered, and the coiled coil starts with Cys91 occupying
the heptad d position followed by Val95 (a), Leu98 (d), and
Leu102 (a). Glu105 (d) and the stutter at Gly109 splay the coiled
coil apart, documented by the increase in coiled-coil radius and
pitch (Figure S2) beyond the regular coiled-coil features (Phillips,
1992). The heptad positions Val113 (a) and Leu116 (d) still showHost & Microbe 7, 314–323, April 22, 2010 ª2010 Elsevier Inc. 315
Figure 2. Disulfide Bond Reduction Decreases the Thermostability
of Tetherin
(A) Circular dichroism analyses of tetherin under native and reducing condi-
tions (DTT). Disulfide bond reduction of tetherin(80-147) reduces the overall
helical content, while tetherin(47-159) is less affected.
(B) Thermostability measurements of tetherin were performed at 222 nm under
native and reducing conditions (DTT), revealing a dramatic change in Tm after
disulfide bond reduction.
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regular values are adopted along the heptad positions Ile120
(a), Leu123 (d), and Leu127 (a) (Figure 3C). The irregularities
that follow are produced by a stutter at Ala130, which tightens
the coiled-coil radius to 4.3 A˚ (Figure S2), and Asn141 (d), which
splays the coiled coil apart (Figures 3C and S2). Despite these
irregularities, the coiled coil also contains stabilizing interactions,
such as salt bridges (Glu105-Lys106, Glu133-Arg138) and an
interhelical hydrogen bond (Asn141) (Figure 3C). All heptad posi-
tions are conserved among the known tetherin sequences.
Modifications in some sequences include an extra helical turn
before Gly100 and/or a deletion of two helical turns determined
by Ala130 (a position) and Val134 (d position) (Figure S3).
The N-Terminal Extracellular Region of Tetherin
Extends the Rod-like Structure
SEC analysis of tetherin(47-159) shows a larger hydrodynamic
radius compared to tetherin(80-149) (Figure 1A). This is further
confirmed by small-angle X-ray scattering analysis (Figure 4A).
Guinier evaluation reveals radii of gyration (Rg) of 47.5 A˚ for teth-316 Cell Host & Microbe 7, 314–323, April 22, 2010 ª2010 Elsevier Inerin(47-159) and 31.9 A˚ for tetherin(80-149). Maximal protein
dimensions (Dmax) of 170 A˚ (tetherin[47-159]) and 110 A˚ (teth-
erin[80-147]) were calculated by the distance distribution func-
tion p(r) (Figure S4). The shapes of the tetherin dimers were
determined ab initio, and the reconstructed models fit the exper-
imental data with the discrepancy c of 1.1 and 1.5, respectively
(Figure 4A). The solution structure of tetherin(80-147) shows an
elongated rod with dimensions of 110 3 45 3 30 A˚, consistent
with the 90 A˚ length of the rod seen in the crystal (Figure 4B). Teth-
erin(47-159) is more elongated and produces a rod with dimen-
sions of 150 3 60 3 45 A˚, confirming that the N-terminal region
extends the coiled-coil part (Figure 4C). Part of the N terminus
in the rod is slightly bent, and its orientation might be determined
by the flexible linkage of the N terminus to the coiled-coil domain,
as indicated by the protease sensitivity of this region (Figure S1).
The Coiled Coil and the N-Terminal Region of Tetherin
Are Required for HIV-1 Retention
We next analyzed whether disruption of coiled-coil residues
influences tetherin function during HIV-1 retention. Two sets of
coiled-coil mutations were designed based on the crystal struc-
ture; set1 (Cys91Gly, Val95Tyr, Leu98Lys, Leu102His) disrupts
the N-terminal part of the coiled coil and set2 (Leu127Lys,
Ala130Tyr, Val134Glu, Leu137Glu) disrupts the C-terminal
region. Recombinant forms of both mutants, tetherin(47-159)_
set1 and tetherin(47-159)_set2, are soluble and elute from a
SEC column in peaks overlapping with that of wild-type teth-
erin(47-159), indicating that the mutations change the hydrody-
namic radius of the proteins (Figure S5A). The mutant proteins
migrate slightly more slowly on SDS-PAGE than wild-type and
reveal reduced disulfide-linked dimerization as determined
under nonreducing SDS-PAGE conditions (Figure S5B). Chemi-
cal crosslinking corroborates further that the mutations interfere
with dimerization; the set1 mutant shows slightly reduced
dimer formation, while set2 mutant shows a more dramatic
reduction in dimerization as judged by the ratio of monomer
dimer bands on SDS-PAGE in comparison to wild-type teth-
erin(47-159) (Figure S5B). This indicates that disruption of the
C-terminal coiled coil leads to a reduced detection of disulfide-
linked dimers in vitro, which is most likely due to a defect in
dimerization as detected by chemical crosslinking. In contrast,
the set1 mutant shows only dramatically reduced disulfide-
linked dimerization, although Cys53 and Cys63 are intact and
could suffice to form disulfide-linked dimers (Andrew et al.,
2009; Perez-Caballero et al., 2009).
Both sets of mutations were introduced into full-length tetherin
containing an internal extracellular HA-tag (tetherin[iHA]) for
expression in 293T cells. This indicates that tetherin(iHA)_set1
and set2 mutants are expressed on the surface of 293T cells
(Figures 5C and 5D); they show membrane staining similar to
that of wild-type tetherin (Neil et al., 2008) and tetherin(iHA),
which appears to concentrate in patches on the plasma mem-
brane (Figure 5B). However, expression of the full-length tetherin
set1 and set2 mutants (C-terminal HA-tag) in cells infected with
Vpu-deficient HIV-1 demonstrates that both mutants are no
longer able to prevent HIV-1 release, as indicated by the detec-
tion of capsid (CA) in the cell culture supernatant at levels similar
to the vector control. In contrast, expression of wild-type tetherin
completely blocks HIV-1 release, as expected (Figure 6A, leftc.
Figure 3. The Crystal Structure of Teth-
erin(80-147)
(A) Stereo image of the experimental electron
density map obtained after SAD phasing and non-
crystallographic symmetry averaging; the heptad
d position occupied by Cys91 forming a disulfide
bond is shown.
(B) Ribbon representation shows a 90 A˚ parallel
coiled coil.
(C) Close-up of the heptad motifs and polar dimer-
ization contacts.
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Crystal Structure of BST-2/Tetherinpanel). This thus implies that proper coiled-coil formation is
required for tetherin function. Both mutants do not affect intra-
cellular processing of Gag and were expressed at similar levels
(Figure 6B, middle and right panels).
Since the extracellular region comprising residues 48–71 is
highly conserved between different species (Figure S3), we
tested two more sets of mutations by replacing conserved
charged and polar side chains. Set3 contains changes within resi-
dues 47–58 (Lys47Ala, Asn49Gly, Glu51Ala, Arg54Ser, Asp55Ala,Cell Host & Microbe 7, 314–3Arg58Ser) and set4 within residues 62–73
(Glu62Ala, Arg64Ser, Asn65Ala, His59Ser,
Gln71Ala,Gln72Ala,Glu73Ser) (FigureS3).
Both mutants are soluble when expressed
as tetherin(47-159) and elute from a SEC
column at the same position as wild-type
tetherin(47-159) (Figure S6A). Further-
more, they form disulfide-linked dimers
that can be efficiently crosslinked (Fig-
ure S6B). Both mutations were then intro-
duced into full-length tetherin(iHA) and
expressed in 293T cells. This demon-
strates that both sets (3 and 4) of tetheri-
n(iHA) mutants are expressed at the
plasma membrane (Figures 5E and 5F).
Although expression of the full-length
set3 mutant reveals its activity in HIV-1
retention at a level comparable to wild-
type (Figure 6B, left panel, lanes 2 and 3),
expression of the set4 mutant shows no
retention activity (Figure 6B, left panel,
lane 4). Cells from all experiments
reveal similar patterns of intracellular Gag
processing (Figure 6B, middle panel).
However, the extensive posttranslational
modification observed for wild-type teth-
erin expression in 293T cells, which
generates a high molecular weight smear,
is less characteristic in the case of the set4
mutant (Figure 6B, right panel, lane 4).
Since the set4 mutant includes muta-
genesis of the glycosylation site at Asn65,
we constructed a single mutant of the
glycosylation site at Asn65, Asn65Gln, to
test whether the loss of retention activity
is due to reduced glycosylation. Although
the Asn65Gln mutant shows a less com-plex expression pattern (Figure 6C, right panel, lane 3), similar
to tetherin_set4, the retention of HIV-1 was only slightly affected.
A small amount of virus could escape, since CA was detected
in the supernatant (Figure 6C, left panel, lane 3). This indicates
that the complete loss of retention observed for the set4
mutant is most likely not due to the changes in posttranslational
modification. Together, our data indicate that a conserved
N-terminal region of the extracellular domain is important for
tetherin function.23, April 22, 2010 ª2010 Elsevier Inc. 317
Figure 4. Small-Angle X-Ray Scattering Analysis of Tetherin
(A) Experimental scattering intensities obtained for tetherin(47-159) (upper
curve) and tetherin(80-147) (lower curve) are shown as a function of resolution
and after averaging and subtraction of solvent scattering. The scattering inten-
sities calculated from representative models (presented in Figures 4B and 4C)
with the lowest c values are shown as red lines. The absolute values of the
intensities of the upper curve are shifted by 2 logarithmic units.
(B and C) Ab initio models of tetherin(80-147) (B) and of tetherin(47-159) (C)
reveal elongated rod-like structures; the calculated bead model as well as
the molecular envelopes with the docked coiled-coil structure are shown.
Figure 5. Cellular Localization of Wild-Type Tetherin and Mutant
Forms of Tetherin
(A–F) Immunofluorescence of mock-transfected 293T cells showing DAPI
staining (A); tetherin(iHA), with the inset showing a close-up of a section of
the plasma membrane, revealing patches of tetherin staining (B); tetheri-
n(iHA-set1) (C); tetherin(iHA-set2) (D); tetherin(iHA-set3) (E); and tetherin
(iHA-set4) (F). All constructs reveal a similar plasma membrane staining
pattern, indicating that the mutations do not affect their localization.
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Crystal Structure of BST-2/TetherinSince the HA-tag of tetherin(iHA) was inserted into a flexible
region (Figure S3) that is disordered in the crystal structure and
sensitive toproteolysis (Figure S1),we tested the effectof the inser-
tion on tetherin function. Expression of tetherin(iHA) reveals318 Cell Host & Microbe 7, 314–323, April 22, 2010 ª2010 Elsevier Ina slightly reduced HIV-1 retention activity in comparison to wild-
type tetherin, as judged by the detection of CA in the supernatant
(Figure 6D, left panel, lanes 2 and 3). Both wild-type and tetheri-
n(iHA) show similar expression patterns (Figure 6D, right panel)
and accumulation of intracellular Gag as compared to the vector
control (Figure 6D, middle panel). This indicates that the conforma-
tional flexibility within residues 80–88 tolerates the insertion of the
HA-tag but slightly reduces the efficacy of HIV-1 retention.
Although we lack high-resolution structural information of the N
terminus, the flexible region accommodating the HA-tag might
correspond to the bent conformation of tetherin(47-159) observed
in the model calculated based on SAXS data (Figure 4C).
DISCUSSION
Tetherin inhibits the release of some enveloped viruses,
including HIV-1, in the absence of Vpu (Neil et al., 2008) byc.
Figure 6. Mutations within the Coiled Coil and the N-Terminal
Region Affect Tetherin Function during HIV-1 Retention
(A) Expression of tetherin_set1 and tetherin_set2 abolishes the retention func-
tion of tetherin. Release of virions (left panel, lanes 3 and 4) is the same as in
case of the vector control (lane 1), whereas wild-type tetherin prevents virion
release (left panel, lane 2). The middle panel shows that intracellular Gag
and its processing are not affected by the expression of mutant tetherin (lanes
3 and 4). The right panel shows the expression levels of mutant (lanes 3 and 4)
and wild-type tetherin (lane 2).
(B) Expression of tetherin_set3 (left panel) has no effect on tetherin function
(lane 3) while tetherin_set4 abolishes the retention function of tetherin (lane
4), as indicated by the extracellular detection of CA. The middle panel shows
that intracellular Gag and its processing are not affected by the expression of
mutant tetherin (lanes 3 and 4). The right panel shows the expression levels of
mutant and wild-type tetherin. Note that the extensive posttranslational modi-
fication observed for wild-type tetherin is absent in case of the set4 mutant.
(C) Expression of the tetherin mutant Asn65Gln (N65Q) (left panel) has little
effect on tetherin function (lane 3) compared to wild-type tetherin (lane 2). Intra-
cellular Gag processing is not affected by the expression of the N65Q mutant
(middle panel, lanes 2 and 3). The right panel shows that the expression pattern
of N65Q (lane 3) is less complex than that of wild-type tetherin (lane 2).
(D) Expression of tetherin(iHA) (left panel) has little effect on tetherin function
(lane 2) when compared to wild-type tetherin (lane 3). The middle panel shows
that intracellular Gag and its processing are not affected. The right panel
shows the expression levels of tetherin(iHA) and wild-type tetherin.
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Cellbridging cellular and viral membranes (Perez-Caballero et al.,
2009) (Fitzpatrick et al., 2010). Our structural analyses
demonstrate that the complete extracellular domain of tetherin
adopts an extended conformation that spans a maximal
distance of 170 A˚. More than half of this is provided by a 90 A˚
long parallel coiled coil. The low-resolution model based on
X-ray scattering data indicates a slightly bent orientation of the
N-terminal domain with respect to the coiled coil. This might
be due to flexibility within the region (residues 79–89) connecting
the N-terminal and coiled-coil domains, as documented by
the sensitivity to proteolysis and the absence of an ordered
structure for residues 80–88. In addition, this region permits
the insertion of a HA-tag epitope without substantial loss of teth-
erin function.
The extracellular rod-like structure must be connected to the
TMR via three N-terminal residues and to the GPI anchor via
one C-terminal residue. Consequently, it is unlikely that tetherin
is positioned parallel between cellular and viral membranes,
which would tether virions quite close to the plasma membrane.
The distance between both membranes would be less than
3–5 nm. Thin-section electron microscopy images support a
larger distance between virions and the plasma membrane
(Neil et al., 2008; Perez-Caballero et al., 2009). Thus, upon virion
tethering, the dimeric tetherin rod has most likely one end
anchored in the plasma membrane and the other one in the virus
membrane, as hypothesized (Perez-Caballero et al., 2009).
The length of the rod and its rather rigid structure in solution
suggest that it functions as a molecular ruler that connects two
entities via a 170 A˚ distance. The importance of the spacer func-
tion is documented by our mutagenesis studies of the coiled-coil
region and by the deletion of the coiled coil (Perez-Caballero
et al., 2009), both of which lead to a loss of the HIV-1 retention
function. Such a molecular ruler function might be also required
to connect adjacent lipid rafts within the plasma membrane
(Kupzig et al., 2003).Host & Microbe 7, 314–323, April 22, 2010 ª2010 Elsevier Inc. 319
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Crystal Structure of BST-2/TetherinSingle cysteine mutations do not affect tetherin function
dramatically, but mutagenesis of all three cysteines led to
a complete loss of function during HIV-1 release (Andrew et al.,
2009; Perez-Caballero et al., 2009), although the mutant is still
active during Lassa and Marburg virus VLP release (Sakuma
et al., 2009b). We show that the presence of disulfide bonds is
crucial for the stability of the extracellular domain, since the Tm
drops to 35C (tetherin[47-159]) under reducing conditions.
The low stability of tetherin under reducing conditions is most
likely due to instability of the coiled coil, which shows an even
lower Tm under reducing conditions. The coiled coil contains
a number of coiled-coil-destabilizing residues occupying central
heptad positions. These positions do not follow classical knobs-
into-holes packing but instead loosen the coiled-coil pitch and
induce an expansion of its radius. Although the coiled-coil region
contains two interhelical salt bridges and one interhelical
hydrogen bond, which are employed to stabilize coiled coils
(Burkhard et al., 2002), the solvent exposure of the apolar heptad
positions (Li et al., 2003) might contribute to the dramatic insta-
bility of the coiled coil in the absence of the disulfide bond.
Together, these structural features explain the low Tm in the
absence of stabilizing disulfide bonds.
This mode of labile coiled-coil interactions might serve two
functions. First, tetherin’s cellular function might involve the
formation of heterodimers with a yet unknown ligand employing
its coiled coil to form more stable dimers. Second, the weak
coiled-coil interactions together with the stabilizing disulfide
bonds generate a dynamic structure, which permits disassembly
and reassembly of the coiled coil during dynamic processes. The
latter function is in agreement with the presence of similar
dynamic or destabilizing coiled-coil features in myosin (Blanken-
feldt et al., 2006; Li et al., 2003), tropomyosin (Brown et al., 2001),
and the streptococcus M1 protein (McNamara et al., 2008) that
have been suggested to be important for their mode of action.
Despite its instability in vitro, we demonstrate the importance
of the coiled coil in vivo. Mutagenesis of N- and C-terminal sets
of highly conserved heptad positions eliminates the tethering
function, although the mutant proteins are still expressed on
the plasma membrane. This indicates that the spacer function
provided by proper coiled-coil formation is essential for tethering.
We also identified a third set of residues within the highly
conserved N-terminal extracellular region that are functionally
required. Mutations within the stretch of residues 48–59 have
no effect on tethering, whereas changes within residues 62–73
lead to a loss of the tethering function. Again, both mutant
proteins are expressed on the plasma membrane, and the extra-
cellular domains form dimers in vitro. Since the set4 mutant elim-
inates the glycosylation site at Asn65 and shows a less complex
expression pattern than wild-type tetherin, we tested whether
changes in posttranslational modification are responsible for
loss of tetherin function. Although the expression pattern of
Asn65Gln resembles that of the set4 mutant, it shows only slightly
reduced HIV-1 retention activity, consistent with previous find-
ings reporting no effect on HIV-1 retention of single and double
glycosylation mutants of tetherin (Andrew et al., 2009). This indi-
cates that mutagenesis of this N-terminal region (set4) either
affects its spacer function or eliminates an important docking
site, possibly for self-assembly. Although Perez-Caballero et al.
reported that the N terminus can be replaced by a similar region320 Cell Host & Microbe 7, 314–323, April 22, 2010 ª2010 Elsevier Inderived from the transferrin receptor and the coiled coil can be
replaced by the dystrophia myotonica protein kinase coiled coil,
it is important to note that the activity of art-tetherin is 10-fold
lower (Perez-Caballero et al., 2009). In contrast, our data clearly
demonstrate that the N-terminal domain and the dynamic fea-
tures of the coiled coil of tetherin are essential for HIV-1 retention.
Based on our structural analysis, we propose the following
interplay between the elongated shape and the conformational
flexibility of tetherin. Although we do not know at which stage
of assembly tetherin enters the virion membrane, it is likely that
it is present from the beginning of assembly starting from lipid
rafts. Since virus assembly and budding is a dynamic process,
tetherin cannot remain too rigid. The coiled-coil instabilities
thus permit a certain degree of flexibility for the tetherin dimers
to diffuse laterally into the budding site with four membrane
anchors while maintaining the strict distance between the
membrane anchors. The conformational flexibility, which entails
most likely opening and reassembly of the coiled coil, is facili-
tated by the presence of the disulfide bonds. Consequently,
dimer dissociation and restabilization do not interfere with the
dynamic process of virus assembly and budding, and tetherin
remains anchored in the newly formed viral membrane, main-
taining its spacer function. Furthermore, the elongated rod-like
structure might be involved in self-assembly, as supported by
the punctate appearance of tetherin in the plasma membrane.
Such clustering might require an intact N-terminal region, which
could cluster tetherin around the membrane neck of a budding
virion, consistent with the accumulation of tetherin at HIV-1
budding sites (Habermann et al., 2010). This would ensure that
at least one or several tetherin dimers can efficiently insert into
the viral membrane to render the system efficient. Finally, the
structural basis, which controls tetherin incorporation into virions
even in the presence of Vpu in some cells without restriction of
HIV-1 release (Fitzpatrick et al., 2010), may depend on its surface
density (Habermann et al., 2010) but remains to be determined.
EXPERIMENTAL PROCEDURES
Bacterial Protein Expression and Purification
cDNA encoding human tetherin/BST-2 residues 47–159 and 80–147 was
cloned into expression vector pETM11. Site-directed mutagenesis of tetherin
(47-159) was carried out using standard protocols and verified by sequencing.
Protein expression was performed in E. coli Rosetta2 cells induced with
isopropyl b-D-1-thiogalactopyranoside (IPTG) at 20C for 4 hr. Cells were lysed
in buffer A (20 mM Tris [pH 8.0], 0.1 M NaCl, 10 mM imidazole), and proteins
were purified by Ni2+ chromatography. The His-tag was removed by tobacco
etch virus (TEV) protease cleavage, and both TEV and uncleaved protein
were removed by Ni2+ chromatography. Final purification steps included
anion-exchange chromatography (mono Q; GE Healthcare; Waukesha, WI) in
buffer B (20 mM bicine [pH 9.3], 0.1 M NaCl, 5 mM EDTA) and size-exclusion
chromatography (Superdex 75; GE Healthcare) in buffer C (20 mM HEPES
[pH 8.0], 0.1 M NaCl, 5 mM EDTA). Selenomethionine-substituted teth-
erin(80-147) and mutant tetherin proteins were purified as described above.
Mutant tetherin constructs contain the following mutations: tetherin_set1,
Cys91Gly, Val95Tyr, Leu98Lys, Leu102His; tetherin_set2, Leu127Lys, Ala130-
Tyr, Val134Glu, Leu137Glu; tetherin_set3, Lys47Ala, Asn49Gly, Glu51Ala,
Arg54Ser, Asp55Ala, Arg58Ser; tetherin_set4, Glu62Ala, Arg64Ser, Asn65Ala,
His59Ser, Gln71Ala, Gln72Ala, Glu73Ser.
Crystallization, Data Collection, and Structure Solution
Tetherin(80-147) was crystallized at a concentration of 5 mg/ml by mixing 1 ml
protein and 1 ml reservoir solution (0.02 M MgCl2, 0.1 M bis tris [pH 5.0], 20%c.
Table 1. Crystallographic Statistics
Data Collection Statistics
Space group C2
Cell dimensions a, b, c; b 169.89 A˚, 85.93 A˚, 123.31 A˚; 126.94
Wavelength (A˚) 0.979
Resolution (A˚) 45.00–2.77 (2.92–2.77)
Rmerge 0.086 (0.479)
Completeness (%) 98.1 (97.7)
I/s(I) 13.8 (3.8)
Redundancy 7.6 (7.7)
Refinement Statistics
Resolution range (A˚) 44.8–2.77
No. reflections 35,361
Rwork/Rfree 0.2407/0.2737
No. protein atoms 4596
No. of ligands/ion 21
No. of waters 126
B factors protein/ligand/water 88.56/62.65/66.31
Rmsd (bonds) (A˚) 0.014
Rmsd (angles) () 1.305
Values in parentheses are for highest-resolution shell.
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supplemented by 26% glycerol and flash-frozen in liquid nitrogen. A SAD
data set was collected at ESRF (Grenoble, France), beamline ID14-4. Data
were indexed and processed with XDS (Kabsch, 1993) and scaled with SCALA
(CCP4, 1994; Evans, 2006). The crystals belong to space group C2 with unit
cell dimensions of a = 169.89A˚, b = 85.93A˚, c = 123.31A˚, and b = 126.94
and contain 11 monomers per asymmetric unit.
Heavy-atom positions were located with SHELXD (Schneider and Sheldrick,
2002), and the correct hand was verified using SHELXE (Sheldrick, 2002). The
experimental phases were calculated using SHARP (Bricogne et al., 2003) and
resulted in an overall figure of merit (FOM) of 0.38/0.10 for the acentric and
centric reflections, respectively. These phases were improved using a 70%
solvent content in SOLOMON (Abrahams and Leslie, 1996). An initial model
was built using RESOLVE (Terwilliger and Berendzen, 1999), which allowed
the determination of the noncrystallographic symmetry operators. The elec-
tron density map was further improved using 11-fold averaging, and the final
model was built manually using the program COOT (Emsley and Cowtan,
2004). The structure was refined to a resolution of 2.77 A˚ with the program
PHENIX (Adams et al., 2002), with an Rfactor of 0.24 and Rfree of 0.27 with
good stereochemistry (Table 1). Most (96.88%) of the residues are within the
preferred and allowed regions of a Ramachandran plot (CCP4, 1994). Chains
A, F, I, and J contain amino acids (aa) 89–147; chain B, aa 89–145; chain C,
aa 89–137; chain D, aa 87–142; chain E, aa 88–146; chain G, aa 88–141;
chain H, aa 89–142; and chain K, aa 89–127. Molecular graphics figures
were generated with PyMOL (http://www.pymol.org). The helical parameters
of the coiled coil were calculated using the program TWISTER (Strelkov and
Burkhard, 2002).
Biophysical and Biochemical Characterization of Tetherin
CD spectroscopy measurements were performed using a JASCO Inc. (Easton,
MD) spectropolarimeter equipped with a thermoelectric temperature con-
troller. Spectra of each sample were recorded at 20C in buffer D (20 mM
phosphate [pH 7], 100 mM NaCl). For thermal denaturation experiments, the
ellipticity was recorded at 222 nm with 1C steps from 20C to 100C, with
a slope of 1C/min. Ellipticity values were converted to mean residue ellipticity.
Proteolysis of tetherin was carried out in buffer C at room temperature (RT)
with a trypsin-to-protein ratio of 1:100 (w/w). Dimerization of tetherin under
reducing conditions was tested as follows: Proteins were reduced with
10 mM DTT and subsequently incubated with 100 mM iodoacetamide at RT
for 1 hr. Unbound DTT and iodoacetamide were removed by dialysis in buffer
C, and samples were crosslinked with 5 mM ethylene glycol bis(succinimidyl
succinate) (EGS). The crosslinking reaction was quenched with 20 mM Tris
(pH 8.0).
Small-Angle X-Ray Scattering Analysis
X-ray scattering data were collected on ESRF (Grenoble) beamline ID14-EH3
at a sample-detector distance of 2.4 m covering a range of momentum transfer
of 0.1 < s < 4.5 nm1 (s = 4p sin(q)/l, where q is the scattering angle and l =
0.15 nm is the X-ray wavelength). The scattering intensity of tetherin(47-159)
was measured at protein concentrations of 2 and 13 mg/ml and that of teth-
erin(80-147) at concentrations of 2 and 11 mg/ml in buffer C. The data were
normalized to the intensity of the incident beam; the scattering of the buffer
was subtracted and the resulting intensities were scaled for concentration.
Data processing was performed using the program package PRIMUS
(Konarev et al., 2003). The forward scattering, I(0), and the Rg were calculated
with GNOM, which also provides the distance distribution function, p(r), of the
particle (Svergun, 1992). Low-resolution models of both tetherin samples were
simulated by the program DAMMIN (Svergun, 1999) and GASBOR (Svergun
et al., 2001), which resulted in similar elongated structures. Figure 4 represents
the GASBOR model. The crystal structure of tetherin(80-147) was docked
into the low-resolution models using the program package SITUS (Wriggers
et al., 1999).
Mammalian Expression Constructs and HIV-1 Release Assay
The coding sequence for full-length human tetherin with an N-terminal HA-tag
(HA-tetherin) or an HA-tag inserted into the extracellular domain between
residues Gln82 and Asp83 (tetherin[iHA]) was cloned into the mammalian
expression vector pBJ5. To examine the effects of WT and mutant tetherinCellon HIV-1 release, 293T cells (1.23 106) were seeded into T25 flasks and trans-
fected 24 hr later using a calcium phosphate precipitation technique. The
cultures were transfected with 1 mg Vpu-negative proviral DNA (HIV-1HXB2)
together with expression vectors for WT or mutant HA-tetherin or the empty
vector (50 ng). The total amount of transfected DNA was brought to 8 mg
with carrier DNA (pTZ18U). Twenty-four hours posttransfection, the cells
were lysed in radioimmunoprecipitation assay buffer (140 mM NaCl, 8 mM
Na2HPO4, 2 mM NaH2PO4, 1% NP-40, 0.5% sodium deoxycholate, 0.05%
SDS), and the culture supernatants were clarified by low-speed centrifugation
and passed through 0.45 mm filters. Virions released into the medium were
pelleted through 20% sucrose cushions by ultracentrifugation for 2 hr at
27,000 rpm and 4C in a Beckman SW41 rotor. Pelletable material and the
cell lysates were analyzed by SDS-PAGE and western blotting, using the
anti-HIV CA antibody 183-H12-5C (Chesebro et al., 1992) to detect Gag
proteins. HA-tagged tetherin was detected with the anti-HA mouse mono-
clonal antibody HA.11.
Immunofluorescence Analysis
Tetherin expression vectors containing the extracellular internal HA-tag
were transfected into 293T cells using standard methods. For indirect immu-
nofluorescence (IIF), 293T cells were cultured on coverslips and fixed with
4% paraformaldehyde for 20 min at 4C. The coverslips were incubated with
an aHA-tag antibody in PBS for 1 hr at RT. Slides were washed three times
with PBS, followed by the secondary antibody incubation at RT for 1 hr (Alexa
488- or 594-coupled anti-mouse or anti-rabbit goat antibodies in PBS). After
three washes with PBS, slides were mounted in Mowiol and analyzed by
confocal microscopy.
ACCESSION NUMBERS
Coordinates and structure factors have been deposited in the Protein Data
Bank with accession number 2x7a.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and can be found with this
article online at doi:10.1016/j.chom.2010.03.005.Host & Microbe 7, 314–323, April 22, 2010 ª2010 Elsevier Inc. 321
Cell Host & Microbe
Crystal Structure of BST-2/TetherinACKNOWLEDGMENTS
This work was supported by the Agence Nationale de la Recherche (ANR-08-
BLAN-0271-01 to W.W.), the Deutsche Forschungsgemeinschaft (DFG
SPP1175 to W.W.), the National Institute of Allergy and Infectious Diseases
(R37AI029873 to H.G.), and a postdoctoral fellowship from the European
Molecular Biology Organization (B.H.). We thank S. Avilov for help with
confocal microscopy and B. Connell for characterization of the first tetherin
constructs. We acknowledge the Partnership for Structural Biology (http://
www.psb-grenoble.eu) for access to the common platforms, including the
crystallization facility (J. Marquez), and the ESRF and EMBL for beam time
and assistance during data collection. The following reagent was obtained
through the AIDS Research and Reference Reagent Program, Division of
AIDS, NIAID, NIH: HIV-1 p24 monoclonal antibody (183-H12-5C) from Bruce
Chesebro and Kathy Wehrly.
Received: December 18, 2009
Revised: February 11, 2010
Accepted: March 8, 2010
Published online: April 15, 2010REFERENCES
Abrahams, J.P., and Leslie, A.G. (1996). Methods used in the structure
determination of bovine mitochondrial F1 ATPase. Acta Crystallogr. D Biol.
Crystallogr. 52, 30–42.
Adams, P.D., Grosse-Kunstleve, R.W., Hung, L.-W., Ioerger, T.R., McCoy,
A.J., Moriarty, N.W., Read, R.J., Sacchettini, J.C., Sauter, N.K., and
Terwilliger, T.C. (2002). PHENIX: building new software for automated crystal-
lographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58,
1948–1954.
Andrew, A.J., Miyagi, E., Kao, S., and Strebel, K. (2009). The formation of
cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1
virus release but not for sensitivity to Vpu. Retrovirology 6, 80.
Bartee, E., McCormack, A., and Fru¨h, K. (2006). Quantitative membrane pro-
teomics reveals new cellular targets of viral immune modulators. PLoS Pathog.
2, e107.
Blankenfeldt, W., Thoma¨, N.H., Wray, J.S., Gautel, M., and Schlichting, I.
(2006). Crystal structures of human cardiac beta-myosin II S2-Delta provide
insight into the functional role of the S2 subfragment. Proc. Natl. Acad. Sci.
USA 103, 17713–17717.
Bricogne, G., Vonrhein, C., Flensburg, C., Schiltz, M., and Paciorek, W. (2003).
Generation, representation and flow of phase information in structure determi-
nation: recent developments in and around SHARP 2.0. Acta Crystallogr.
D Biol. Crystallogr. 59, 2023–2030.
Brown, J.H., Kim, K.H., Jun, G., Greenfield, N.J., Dominguez, R., Volkmann,
N., Hitchcock-DeGregori, S.E., and Cohen, C. (2001). Deciphering the design
of the tropomyosin molecule. Proc. Natl. Acad. Sci. USA 98, 8496–8501.
Burkhard, P., Ivaninskii, S., and Lustig, A. (2002). Improving coiled coil stability
by optimizing ionic interactions. J. Mol. Biol. 318, 901–910.
CCP4 (Collaborative Computational Project, Number 4) (1994). The CCP4
suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystal-
logr. 50, 760–763.
Chesebro, B., Wehrly, K., Nishio, J., and Perryman, S. (1992). Macrophage-
tropic human immunodeficiency virus isolates from different patients exhibit
unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic
isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66,
6547–6554.
Douglas, J.L., Viswanathan, K., McCarroll, M.N., Gustin, J.K., Fru¨h, K., and
Moses, A.V. (2009). Vpu directs the degradation of the human immunodefi-
ciency virus restriction factor BST-2/Tetherin via a betaTrCP-dependent
mechanism. J. Virol. 83, 7931–7947.
Emsley, P., and Cowtan, K. (2004). Coot: model-building tools for molecular
graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132.322 Cell Host & Microbe 7, 314–323, April 22, 2010 ª2010 Elsevier InEvans, P. (2006). Scaling and assessment of data quality. Acta Crystallogr.
D Biol. Crystallogr. 62, 72–82.
Fitzpatrick, K., Skasko, M., Deerinck, T.J., Crum, J., Ellisman, M.H., and
Guatelli, J. (2010). Direct restriction of virus release and incorporation of the
interferon-induced protein BST-2 into HIV-1 particles. PLoS Pathog. 6,
e1000701.
Goffinet, C., Allespach, I., Homann, S., Tervo, H.M., Habermann, A., Rupp, D.,
Oberbremer, L., Kern, C., Tibroni, N., Welsch, S., et al. (2009). HIV-1 antago-
nism of CD317 is species specific and involves Vpu-mediated proteasomal
degradation of the restriction factor. Cell Host Microbe 5, 285–297.
Goto, T., Kennel, S.J., Abe, M., Takishita, M., Kosaka, M., Solomon, A., and
Saito, S. (1994). A novel membrane antigen selectively expressed on terminally
differentiated human B cells. Blood 84, 1922–1930.
Go¨ttlinger, H.G., Dorfman, T., Cohen, E.A., and Haseltine, W.A. (1993). Vpu
protein of human immunodeficiency virus type 1 enhances the release of
capsids produced by gag gene constructs of widely divergent retroviruses.
Proc. Natl. Acad. Sci. USA 90, 7381–7385.
Gramberg, T., Sunseri, N., and Landau, N.R. (2009). Accessories to the crime:
recent advances in HIV accessory protein biology. Curr. HIV/AIDS Rep. 6,
36–42.
Gupta, R.K., Hue´, S., Schaller, T., Verschoor, E., Pillay, D., and Towers, G.J.
(2009). Mutation of a single residue renders human tetherin resistant to
HIV-1 Vpu-mediated depletion. PLoS Pathog. 5, e1000443.
Habermann, A., Krijnse Locker, J., Oberwinkler, H., Eckhardt, M., Homann, S.,
Andrew, A., Strebel, K., and Kra¨usslich, H.-G. (2010). CD317/Tetherin is
enriched in the HIV-1 envelope 1 and downregulated from the plasma
membrane upon virus infection. J. Virol., in press. Published online February
10, 2010. 10.1128/JVI.02421-09.
Harila, K., Salminen, A., Prior, I., Hinkula, J., and Suomalainen, M. (2007). The
Vpu-regulated endocytosis of HIV-1 Gag is clathrin-independent. Virology
369, 299–308.
Jia, B., Serra-Moreno, R., Neidermyer, W., Rahmberg, A., Mackey, J., Fofana,
I.B., Johnson, W.E., Westmoreland, S., and Evans, D.T. (2009). Species-
specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by teth-
erin/BST2. PLoS Pathog. 5, e1000429.
Jouvenet, N., Neil, S.J., Zhadina, M., Zang, T., Kratovac, Z., Lee, Y., McNatt,
M., Hatziioannou, T., and Bieniasz, P.D. (2009). Broad-spectrum inhibition of
retroviral and filoviral particle release by tetherin. J. Virol. 83, 1837–1844.
Kabsch, W. (1993). Automatic processing of rotation diffraction data from
crystals of initially unknown symmetry and cell constants. J. Appl. Cryst. 26,
795–800.
Kaletsky, R.L., Francica, J.R., Agrawal-Gamse, C., and Bates, P. (2009). Teth-
erin-mediated restriction of filovirus budding is antagonized by the Ebola
glycoprotein. Proc. Natl. Acad. Sci. USA 106, 2886–2891.
Kawai, S., Azuma, Y., Fujii, E., Furugaki, K., Ozaki, S., Matsumoto, T., Kosaka,
M., and Yamada-Okabe, H. (2008). Interferon-alpha enhances CD317 expres-
sion and the antitumor activity of anti-CD317 monoclonal antibody in renal cell
carcinoma xenograft models. Cancer Sci. 99, 2461–2466.
Klimkait, T., Strebel, K., Hoggan, M.D., Martin, M.A., and Orenstein, J.M.
(1990). The human immunodeficiency virus type 1-specific protein vpu is
required for efficient virus maturation and release. J. Virol. 64, 621–629.
Konarev, P.V., Volkov, V.V., Sokolova, A.V., Koch, M.H.J., and Svergun, D.I.
(2003). PRIMUS: a Windows PC-based system for small-angle scattering
data analysis. J. Appl. Cryst. 36, 1277–1282.
Kupzig, S., Korolchuk, V., Rollason, R., Sugden, A., Wilde, A., and Banting, G.
(2003). Bst-2/HM1.24 is a raft-associated apical membrane protein with an
unusual topology. Traffic 4, 694–709.
Li, Y., Brown, J.H., Reshetnikova, L., Blazsek, A., Farkas, L., Nyitray, L., and
Cohen, C. (2003). Visualization of an unstable coiled coil from the scallop
myosin rod. Nature 424, 341–345.
Malim, M.H., and Emerman, M. (2008). HIV-1 accessory proteins—ensuring
viral survival in a hostile environment. Cell Host Microbe 3, 388–398.
Mangeat, B., Gers-Huber, G., Lehmann, M., Zufferey, M., Luban, J., and
Piguet, V. (2009). HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2c.
Cell Host & Microbe
Crystal Structure of BST-2/Tetherinby binding it and directing its beta-TrCP2-dependent degradation. PLoS
Pathog. 5, e1000574.
Masuyama, N., Kuronita, T., Tanaka, R., Muto, T., Hirota, Y., Takigawa, A.,
Fujita, H., Aso, Y., Amano, J., and Tanaka, Y. (2009). HM1.24 is internalized
from lipid rafts by clathrin-mediated endocytosis through interaction with
alpha-adaptin. J. Biol. Chem. 284, 15927–15941.
McNamara, C., Zinkernagel, A.S., Macheboeuf, P., Cunningham, M.W., Nizet,
V., and Ghosh, P. (2008). Coiled coil irregularities and instabilities in group A
Streptococcus M1 are required for virulence. Science 319, 1405–1408.
McNatt, M.W., Zang, T., Hatziioannou, T., Bartlett, M., Fofana, I.B., Johnson,
W.E., Neil, S.J., and Bieniasz, P.D. (2009). Species-specific activity of HIV-1
Vpu and positive selection of tetherin transmembrane domain variants.
PLoS Pathog. 5, e1000300.
Mitchell, R.S., Katsura, C., Skasko, M.A., Fitzpatrick, K., Lau, D., Ruiz, A.,
Stephens, E.B., Margottin-Goguet, F., Benarous, R., and Guatelli, J.C.
(2009). Vpu antagonizes BST-2-mediated restriction of HIV-1 release via
beta-TrCP and endo-lysosomal trafficking. PLoS Pathog. 5, e1000450.
Miyagi, E., Andrew, A.J., Kao, S., and Strebel, K. (2009). Vpu enhances HIV-1
virus release in the absence of Bst-2 cell surface down-modulation and intra-
cellular depletion. Proc. Natl. Acad. Sci. USA 106, 2868–2873.
Neil, S.J., Sandrin, V., Sundquist, W.I., and Bieniasz, P.D. (2007). An interferon-
alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle
release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe 2,
193–203.
Neil, S.J., Zang, T., and Bieniasz, P.D. (2008). Tetherin inhibits retrovirus
release and is antagonized by HIV-1 Vpu. Nature 451, 425–430.
Ohtomo, T., Sugamata, Y., Ozaki, Y., Ono, K., Yoshimura, Y., Kawai, S.,
Koishihara, Y., Ozaki, S., Kosaka, M., Hirano, T., and Tsuchiya, M. (1999).
Molecular cloning and characterization of a surface antigen preferentially over-
expressed on multiple myeloma cells. Biochem. Biophys. Res. Commun. 258,
583–591.
Perez-Caballero, D., Zang, T., Ebrahimi, A., McNatt, M.W., Gregory, D.A.,
Johnson, M.C., and Bieniasz, P.D. (2009). Tetherin inhibits HIV-1 release by
directly tethering virions to cells. Cell 139, 499–511.
Phillips, G.N., Jr. (1992). What is the pitch of the a-helical coiled coil? Proteins
14, 425–429.
Rong, L., Zhang, J., Lu, J., Pan, Q., Lorgeoux, R.P., Aloysius, C., Guo, F., Liu,
S.L., Wainberg, M.A., and Liang, C. (2009). The transmembrane domain of
BST-2 determines its sensitivity to down-modulation by human immunodefi-
ciency virus type 1 Vpu. J. Virol. 83, 7536–7546.
Sakuma, T., Noda, T., Urata, S., Kawaoka, Y., and Yasuda, J. (2009a). Inhibi-
tion of Lassa and Marburg virus production by tetherin. J. Virol. 83, 2382–2385.CellSakuma, T., Sakurai, A., and Yasuda, J. (2009b). Dimerization of tetherin is not
essential for its antiviral activity against Lassa and Marburg viruses. PLoS ONE
4, e6934.
Sauter, D., Schindler, M., Specht, A., Landford, W.N., Mu¨nch, J., Kim, K.-A.,
Votteler, J., Schubert, U., Bibollet-Ruche, F., Keele, B.F., et al. (2009). Teth-
erin-driven adaptation of Vpu and Nef function and the evolution of pandemic
and nonpandemic HIV-1 strains. Cell Host Microbe 6, 409–421.
Schneider, T.R., and Sheldrick, G.M. (2002). Substructure solution with
SHELXD. Acta Crystallogr. D Biol. Crystallogr. 58, 1772–1779.
Sheldrick, G.M. (2002). Macromolecular phasing with SHELXE. Z. Kristallogr.
217, 644–650.
Strebel, K., Klimkait, T., Maldarelli, F., and Martin, M.A. (1989). Molecular and
biochemical analyses of human immunodeficiency virus type 1 vpu protein.
J. Virol. 63, 3784–3791.
Strebel, K., Luban, J., and Jeang, K.T. (2009). Human cellular restriction
factors that target HIV-1 replication. BMC Med. 7, 48.
Strelkov, S.V., and Burkhard, P. (2002). Analysis of alpha-helical coiled coils
with the program TWISTER reveals a structural mechanism for stutter
compensation. J. Struct. Biol. 137, 54–64.
Svergun, D.I. (1992). Determination of the regularization parameter in indirect-
transform methods using perceptual criteria. J. Appl. Cryst. 25, 495–503.
Svergun, D.I. (1999). Restoring low resolution structure of biological macro-
molecules from solution scattering using simulated annealing. Biophys. J.
76, 2879–2886.
Svergun, D.I., Petoukhov, M.V., and Koch, M.H. (2001). Determination of
domain structure of proteins from X-ray solution scattering. Biophys. J. 80,
2946–2953.
Terwilliger, T.C., and Berendzen, J. (1999). Automated MAD and MIR structure
solution. Acta Crystallogr. D Biol. Crystallogr. 55, 849–861.
Terwilliger, E.F., Cohen, E.A., Lu, Y.C., Sodroski, J.G., and Haseltine, W.A.
(1989). Functional role of human immunodeficiency virus type 1 vpu. Proc.
Natl. Acad. Sci. USA 86, 5163–5167.
Van Damme, N., Goff, D., Katsura, C., Jorgenson, R.L., Mitchell, R., Johnson,
M.C., Stephens, E.B., and Guatelli, J. (2008). The interferon-induced protein
BST-2 restricts HIV-1 release and is downregulated from the cell surface by
the viral Vpu protein. Cell Host Microbe 3, 245–252.
Wriggers, W., Milligan, R.A., and McCammon, J.A. (1999). Situs: A package for
docking crystal structures into low-resolution maps from electron microscopy.
J. Struct. Biol. 125, 185–195.
Zhang, F., Wilson, S.J., Landford, W.C., Virgen, B., Gregory, D., Johnson,
M.C., Munch, J., Kirchhoff, F., Bieniasz, P.D., and Hatziioannou, T. (2009).
Nef proteins from simian immunodeficiency viruses are tetherin antagonists.
Cell Host Microbe 6, 54–67.Host & Microbe 7, 314–323, April 22, 2010 ª2010 Elsevier Inc. 323
